Kindergarten teachers would be proud -- instead of battling to beat out their competitors, these companies are relying on a cooperative strategy that could benefit everyone involved -- including investors.
When it comes to outmaneuvering big pharma for market share, most small biotechs don’t stand a chance. Every once in a while you’ll see a David take down a Goliath, but most of the time, the giants are a safer bet. But some smart smaller companies have found ways to “play nicely” with their larger competitors by improving the efficacy of existing treatments marketed by those competitors -- a strategy that could pay off big for investors in these stocks.
Hey, check out all the research scientist jobs. Post your resume today!
